Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 24, 2012Current Opinion in Rheumatology

Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition

View Full Paper
Ask AI
Bookmark
Share

Authors

UKUta KiltzRheumazentrum RuhrgebietFHF. HeldmannKlinikum ChemnitzXBXenofon BaraliakosRheumazentrum Ruhrgebiet

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kiltz et al. (2012) studied this question.

synapsesocial.com/papers/6a91479680800acc7233fa01https://doi.org/10.1097/bor.0b013e3283524b82
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.1991 · 1,203 citations
  2. 2Ankylosing Spondylitis Refractory to Tumor Necrosis Factor Blockade Responds to Tocilizumab2011 · 36 citations
  3. 3Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis2011 · 17 citations